Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventional

A Pilot Trial to Evaluate the Effectiveness of Navigation, Interactive Web Education, or the Combination of Both to Promote Guideline-Concordant Colorectal Cancer Surveillance Care

NCT ID: NCT06995924Sponsor: Fred Hutchinson Cancer CenterLast updated: 2026-02-20

Summary

This pilot clinical trial looks at whether patient navigation services, an interactive web education intervention, called Current Together After Cancer (CTAC), or both navigation and CTAC works to improve the uptake of surveillance in patients with stage I-III colorectal cancer (CRC). Post-treatment surveillance is critical to detect recurrence early, yet many CRC survivors do not receive recommended surveillance care. Surveillance is a complex process that includes laboratory tests, cross-sectional imaging, and endoscopic procedures. Patient navigation services, interactive web education, or a combination of both may improve surveillance care for patients with stage I-III colorectal cancer.

Detailed description

OUTLINE: Patients are assigned to 1 of 3 arms based on the clinic location they receive cancer care at. ARM A (VIRGINIA MASON): Patients receive access to navigation services, including education on surveillance care, reminders to complete care and assistance in scheduling surveillance, within 3 months of standard of care surgical resection for stage I-III CRC. ARM B (FRED HUTCH \[SOUTH LAKE UNION\]): Patients receive access to the CTAC intervention, which includes self-directed, interactive web-based education about surveillance and a checklist of care, within 3 months of standard of care surgical resection for stage I-III CRC. ARM C (FRED HUTCH \[OVERLAKE + EVERGREEN\]): Patients receive access to navigation services, including education on surveillance care, reminders to complete care and assistance in scheduling surveillance, and access to the CTAC intervention, which includes self-directed, interactive web-based education about surveillance and a checklist of care, within 3 months of standard of care surgical resection for stage I-III CRC. Patients are followed up at 3 months post study-enrollment and 12-18 months after surgical resection.

Arms & interventions

  • OtherEducational Intervention

    Complete self-directed interactive education

  • OtherElectronic Health Record Review

    Ancillary studies

  • OtherInternet-Based Intervention

    Receive access to CTAC

  • BehavioralPatient Navigation

    Receive patient navigation services

  • OtherSurvey Administration

    Ancillary studies

Outcome measures

Primary

  • Completion of colonoscopy (stage I colorectal carcinoma patients)

    Time frame: Up to 18 months post-surgical resection

  • Completing any colonoscopy, carcinoembryonic antigen tumor marker (CEA), and cross-sectional imaging (stage II-III colorectal carcinoma patients)

    Will compare rates of surveillance care completion 1-year (up to 18 months accounting for delays that may be due to inability accessing endoscopy) post-surgical resection across groups using chi-square tests. Will use a multivariable logistic regression model to test for factors that may be associated with increased or decreased surveillance care including patient-level demographic factors (e.g., age, sex, etc.) and available clinic-level factors (e.g., clinic size, etc.).

    Time frame: Up to 18 months post-surgical resection

Secondary

  • Knowledge of colorectal cancer (CRC) surveillance

    Time frame: At baseline, and 3 months post enrollment

  • Self-efficacy to complete CRC surveillance

    Time frame: At baseline, and 3 months post enrollment

  • Acceptability of the intervention

    Time frame: At 3 months post enrollment

  • Intervention appropriateness

    Time frame: At 3 months post enrollment

  • Feasibility of the intervention

    Time frame: At 3 months post enrollment

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: No
Inclusion Criteria: * Age ≥ 18 due to disease and clinic population * Stage I-III CRC survivor within 3 months post-surgical resection * Being seen at a participating clinic * Ability to understand and complete surveys in English

Study locations (2)

Benaroya Research Institute at Virginia Mason

Seattle, Washington, 98101

Recruiting
Vlad Simianu, MD, MPH, FACS, FASCRS · Principal Investigator

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, 98109

Recruiting
Ari Bell-Brown · Contact
Rachel B. Issaka, MD, MAS · Principal Investigator